http://saudijgastro.com/article.asp...ume=22;issue=5;spage=353;epage=359;aulast=Jia
Interesting that this paper came out of China, and funded within China.
Zhongzhi Jia1, Guomin Jiang1, Feng Tian1, Chunfu Zhu2, Xihu Qin2
1 Department of Interventional Radiology, Changzhou No. 2 People's Hospital, Nanjing Medical University, Changzhou, 213003, Jiangsu Province, China
2 Department of General Surgery, Changzhou No. 2 People's Hospital, Nanjing Medical University, Changzhou, 213003, Jiangsu Province, China
......
Column 1 Column 2 Column 3 0 mce-anchor Conclusions
090 Y radioembolization is a safe and effective treatment for HCC and PVTT. However, this study lacks adequate power to draw definitive conclusions based on the presented data. A larger cohort might allow more meaningful conclusions and more robust survival data.
Financial support and sponsorship
This study was supported by High-level Medical Talents Training Project of Changzhou (NO. 2016CZBJ009 and NO. 2016CZLJ007). Social Development Fund of Jiangsu Science and Technology (NO. BE2016658). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis
Add to My Watchlist
What is My Watchlist?